» Articles » PMID: 33005184

Integrative Analysis of Membrane Proteome and MicroRNA Reveals Novel Lung Cancer Metastasis Biomarkers

Overview
Journal Front Genet
Date 2020 Oct 2
PMID 33005184
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Lung cancer is one of the most common human cancers both in incidence and mortality, with prognosis particularly poor in metastatic cases. Metastasis in lung cancer is a multifarious process driven by a complex regulatory landscape involving many mechanisms, genes, and proteins. Membrane proteins play a crucial role in the metastatic journey both inside tumor cells and the extra-cellular matrix and are a viable area of research focus with the potential to uncover biomarkers and drug targets. In this work we performed membrane proteome analysis of highly and poorly metastatic lung cells which integrated genomic, proteomic, and transcriptional data. A total of 1,762 membrane proteins were identified, and within this set, there were 163 proteins with significant changes between the two cell lines. We applied the Tied Diffusion through Interacting Events method to integrate the differentially expressed disease-related microRNAs and functionally dys-regulated membrane protein information to further explore the role of key membrane proteins and microRNAs in multi-omics context. was revealed as a key gene involved in the activity of membrane proteins by targeting MET and PXN, affecting membrane proteins through protein-protein interaction mechanism. Furthermore, we found that the membrane proteins CDH2, EGFR, ITGA3, ITGA5, ITGB1, and CALR may have significant effect on cancer prognosis and outcomes, which were further validated . Our study provides multi-omics-based network method of integrating microRNAs and membrane proteome information, and uncovers a differential molecular signatures of highly and poorly metastatic lung cancer cells; these molecules may serve as potential targets for giant-cell lung metastasis treatment and prognosis.

Citing Articles

The Fibrosis-Targeted Collagen/Integrins Gene Profile Predicts Risk of Metastasis in Pulmonary Neuroendocrine Neoplasms.

Prieto T, Machado-Rugolo J, Baldavira C, Velosa A, Teodoro W, Ab Saber A Front Oncol. 2021; 11:706141.

PMID: 34458147 PMC: 8385766. DOI: 10.3389/fonc.2021.706141.

References
1.
Gentile A, Trusolino L, Comoglio P . The Met tyrosine kinase receptor in development and cancer. Cancer Metastasis Rev. 2008; 27(1):85-94. DOI: 10.1007/s10555-007-9107-6. View

2.
Vadakekolathu J, Al-Juboori S, Johnson C, Schneider A, Buczek M, Di Biase A . MTSS1 and SCAMP1 cooperate to prevent invasion in breast cancer. Cell Death Dis. 2018; 9(3):344. PMC: 5832821. DOI: 10.1038/s41419-018-0364-9. View

3.
Rothschild S, Gautschi O, Haura E, Johnson F . Src inhibitors in lung cancer: current status and future directions. Clin Lung Cancer. 2010; 11(4):238-42. DOI: 10.3816/CLC.2010.n.030. View

4.
Ma K, Pan X, Fan P, He Y, Gu J, Wang W . Loss of miR-638 in vitro promotes cell invasion and a mesenchymal-like transition by influencing SOX2 expression in colorectal carcinoma cells. Mol Cancer. 2014; 13:118. PMC: 4039649. DOI: 10.1186/1476-4598-13-118. View

5.
Zhao J, Sun F, Liu S, Yang J, Wu Y, Li G . Expression of connexin 43 and E-cadherin protein and mRNA in non-small cell lung cancers in Chinese patients. Asian Pac J Cancer Prev. 2013; 14(2):639-43. DOI: 10.7314/apjcp.2013.14.2.639. View